Quadrant Management

Vantem Global is a manufacturer specializing in a proprietary panel sheet system designed for construction applications. The company focuses on streamlining the building process by utilizing structural insulated panels to create volumetric modules in a factory setting. These modules are then transported to construction sites for final assembly. Vantem’s panels are weather-resistant, thermally efficient, and finish-ready, allowing for the rapid delivery of energy-efficient, climate-resistant homes and other structures. By enhancing the construction process, Vantem enables builders to reduce costs and financing expenses while accelerating project timelines, ultimately increasing profitability.

Wandercraft is a pioneering company that develops and sells advanced exoskeletons designed to enable autonomous, self-balanced walking for individuals with mobility impairments. Its flagship product, Atalante, which received CE marking in 2019, is utilized in European rehabilitation hospitals to facilitate gait re-learning treatments. The company is in the process of obtaining FDA approval for its technology. Wandercraft's exoskeletons are distinguished by their realistic gait capabilities, allowing users to walk without crutches or additional aids. In addition to its rehabilitation products, the company is also working on a more agile Personal Mobility exoskeleton intended for everyday use. Wandercraft integrates expertise in algorithmics, artificial intelligence, robotics, production, and clinical practices, positioning itself as a leader in the development of innovative mobility solutions for paraplegics and individuals with myopathic conditions.

SyncThink Inc. is a neuro-technology company based in Palo Alto, California, that specializes in eye-tracking technology for brain health analytics. Founded in 2009 by neurosurgeon Dr. Jamshid Ghajar, the company has developed the EYE-SYNC device, a non-invasive, head-mounted eye-tracking system designed to provide medical professionals with objective metrics related to visual attention and dynamic orientation. EYE-SYNC performs a rapid, 60-second assessment to identify ocular motor impairments and vestibular dysfunction, which are critical components in concussion evaluation. This technology is utilized by various university athletic departments and medical facilities, including Stanford University and Massachusetts General Hospital, for brain health assessment and recovery monitoring. SyncThink's innovations are backed by numerous partnerships with leading research institutions and have received FDA approval, making them applicable in military and athletic contexts as well as in broader applications related to attention development and brain performance. The company holds multiple patents related to its technology and analytics, further solidifying its position in the neuro-diagnostics field.

SyncThink Inc. is a neuro-technology company based in Palo Alto, California, that specializes in eye-tracking technology for brain health analytics. Founded in 2009 by neurosurgeon Dr. Jamshid Ghajar, the company has developed the EYE-SYNC device, a non-invasive, head-mounted eye-tracking system designed to provide medical professionals with objective metrics related to visual attention and dynamic orientation. EYE-SYNC performs a rapid, 60-second assessment to identify ocular motor impairments and vestibular dysfunction, which are critical components in concussion evaluation. This technology is utilized by various university athletic departments and medical facilities, including Stanford University and Massachusetts General Hospital, for brain health assessment and recovery monitoring. SyncThink's innovations are backed by numerous partnerships with leading research institutions and have received FDA approval, making them applicable in military and athletic contexts as well as in broader applications related to attention development and brain performance. The company holds multiple patents related to its technology and analytics, further solidifying its position in the neuro-diagnostics field.